Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing

Contributed by: PR Newswire

Tags

ARCTIC-THERAPEUTICS

More Like This

BioArctic and Eisai sign research evaluation agreement regarding BAN2802

EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics

Long-term treatment data for lecanemab to be presented at AAIC 2024

BioArctic: Professor Lars Lannfelt, awarded Fondation Recherche Alzheimer's European Grand Prix for his contributions to science and treatment of Alzheimer's disease

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

Lecanemab winner in two categories at The Scrip Awards 2023

Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile